Articles

FDA sent a warning letter to Clientele for CGMP violations at the company’s Sunrise, FL facility that included a lack of an adequate quality unit.

Florida Company Receives FDA Warning Letter

Administration of the COVID-19 vaccination from Oxford University and AstraZeneca is expected to begin in the UK in early 2021.

Oxford/AstraZeneca Vaccine Granted Emergency Use Approval in UK

A report in the New England Journal of Medicine states preliminary results from a Phase III clinical trial shows the vaccine is 94.1% effective.

Phase III Data on Moderna COVID-19 Vaccine Supports Its Effectiveness, says Report

Sunstar Americas is expanding its voluntary recall of Paroex Chlorhexidine Gluconate Oral Rinse USP, 0.12% products because of Burkholderia lata contamination.

Recall of Paroex Oral Rinse Expanded

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

President Trump signed the COVID-19 package, which appropriates $2.3 trillion to finance the federal government through September 2021 and provides support for individuals and entities suffering from the economic crisis wrought by the pandemic. 

Pandemic Relief Legislation Provides Economic Assistance, Boosts Federal Budgets

The agency is targeting websites that market untested CBD products as medical treatments.

FDA Sends Warning Letters Citing Illegal Promotion of CBD Products

Customceutical Compounding was sent a warning letter by FDA after investigators found deficiencies in the production of sterile drug products.

Compounder Receives FDA Warning Letter

The agency is organizing a second public meeting on January 8, 2021 to discuss the assessment, approval, and roll-out of new COVID-19 vaccines.

EMA to Hold its Second Public Meeting on COVID-19 Vaccines

The virtual manufacturer and distributor of specialty materials acquired the NY-based company, adding analytical and manufacturing expertise.

Aceto Acquires IsleChem

The UK company is investing £3 million in new instrumentation and equipment to strengthen its high-throughput screening and translational oncology service offerings.

News